论文部分内容阅读
本文对27例不能手术的晚期食管癌患者,采用支气管动脉、胃左动脉灌注,鳞癌以 DMVC 方案,腺癌以 FAM 方案为主的化疗药物。取得了一定的近期疗效,达到了提高生存质量、延长生命之目的。笔者重点对其介入治疗的适应证及理论依据进行了讨论。
In this article, 27 patients with advanced esophageal cancer who are inoperable are treated with bronchial artery and left gastric artery perfusion, DMCC protocol for squamous cell carcinoma, and FAM chemotherapy drug for adenocarcinoma. Achieved a certain short-term curative effect, achieved the purpose of improving the quality of life and prolonging life. The author focused on the indications and theoretical basis for interventional therapy.